Haloxen

Haloxen is a prescription medication containing the antipsychotic agent haloperidol. It is supplied in oral dosage form, though specific strength may vary by market. Haloperidol belongs to the butyrophenone class and acts as a dopamine D2 receptor antagonist. Haloxen is marketed in the European Union and is used under medical supervision for certain psychiatric conditions. It is classified as a prescription‑only product and should be prescribed by a healthcare professional.

Haloxen (haloperidol) is indicated for the management of certain psychotic disorders.

- Schizophrenia, including maintenance therapy - Acute psychotic episodes, such as those associated with mania or severe stress - Short‑term control of agitation in hospitalized patients - Adjunctive treatment of Tourette syndrome when other therapies are insufficient - Management of delirium in intensive care settings when non‑pharmacologic measures are inadequate

Side effects of haloperidol may vary in frequency and severity.

Common: - Drowsiness or sedation - Extrapyramidal symptoms such as tremor or rigidity - Dry mouth - Constipation - Blurred vision - Weight gain

Serious: - Neuroleptic malignant syndrome - Tardive dyskinesia - Severe hypotension - Cardiac arrhythmias (QT prolongation) - Agranulocytosis - Seizures

When prescribing Haloxen, clinicians should consider several precautionary factors.

- History of cardiovascular disease or prolonged QT interval - Pre‑existing movement disorders or Parkinsonian symptoms - Elderly patients, especially those with dementia‑related psychosis, due to increased mortality risk - Hepatic or renal impairment may require dose adjustment - Pregnancy and lactation status unknown; use only if benefit outweighs risk - Concomitant use with other central nervous system depressants

Haloperidol can interact with other medications, affecting its efficacy or safety.

Avoid: - Other antipsychotics or dopamine antagonists (increased risk of extrapyramidal effects) - Drugs that prolong QT interval (e.g., certain antiarrhythmics, macrolide antibiotics) - Strong CYP3A4 inhibitors such as ketoconazole (increased haloperidol levels)

Use with caution: - CNS depressants including benzodiazepines or opioids (enhanced sedation) - Anticholinergic agents (may mask extrapyramidal symptoms) - CYP3A4 inducers like rifampin (reduced haloperidol levels)